1. Home
  2. MOV vs VNDA Comparison

MOV vs VNDA Comparison

Compare MOV & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Movado Group Inc.

MOV

Movado Group Inc.

HOLD

Current Price

$23.55

Market Cap

481.7M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$7.84

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOV
VNDA
Founded
1961
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
481.7M
474.0M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
MOV
VNDA
Price
$23.55
$7.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$31.50
$14.90
AVG Volume (30 Days)
108.7K
3.5M
Earning Date
01-01-0001
05-13-2026
Dividend Yield
5.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$216,105,000.00
Revenue This Year
$2.30
$21.50
Revenue Next Year
$1.17
$38.67
P/E Ratio
$25.52
N/A
Revenue Growth
N/A
8.72
52 Week Low
$12.85
$3.81
52 Week High
$25.85
$9.60

Technical Indicators

Market Signals
Indicator
MOV
VNDA
Relative Strength Index (RSI) 43.58 52.82
Support Level $20.46 $4.25
Resistance Level $25.54 $8.29
Average True Range (ATR) 0.74 0.53
MACD -0.25 0.07
Stochastic Oscillator 7.76 63.39

Price Performance

Historical Comparison
MOV
VNDA

About MOV Movado Group Inc.

Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: